Results 171 to 180 of about 11,119 (184)

Cognitive and Antismoking Effects of Varenicline in Patients With Schizophrenia or Schizoaffective Disorder

Schizophrenia Research, 2009
Robert C. Smith, Abel Lajtha
exaly  

Varenicline for Tobacco Dependence

New England Journal of Medicine, 2008
J Taylor Hays, Jon O Ebbert
exaly  

Varenicline Versus Bupropion SR or Placebo for Smoking Cessation: A Pooled Analysis

American Journal of Health Behavior, 2008
Kathryn E Williams, Elbert Glover
exaly  

Varenicline

Reactions Weekly, 2019
openaire   +2 more sources

Cardiovascular and Neuropsychiatric Events After Varenicline Use for Smoking Cessation

American Journal of Respiratory and Critical Care Medicine, 2018
Peter Selby, Paul Kurdyak, Andrea S Gershon   +2 more
exaly  

Varenicline

Reactions Weekly, 2022
openaire   +1 more source

Discovery and Development of Varenicline for Smoking Cessation

Expert Opinion on Drug Discovery, 2018
Zheng-Xiong Xi, Chloe J. Jordan
exaly  

A Double-Blind Randomized Placebo-Controlled Pilot Study of Neuropsychiatric Adverse Events in Abstinent Smokers Treated With Varenicline or Placebo

Biological Psychiatry, 2011
Li-Jung Tseng, Dahlia Garza
exaly  

Pharmacological Profile of the α4β2 Nicotinic Acetylcholine Receptor Partial Agonist Varenicline, an Effective Smoking Cessation Aid

Neuropharmacology, 2007
exaly  

Safety and Drug Utilization Profile of Varenicline as Used in General Practice in England

Drug Safety, 2009
Lynda V Wilton, Saad A W Shakir
exaly